Alessandro Bartoloni to Treatment Outcome
This is a "connection" page, showing publications Alessandro Bartoloni has written about Treatment Outcome.
Connection Strength
0.102
-
Cryptic severe Plasmodium falciparum malaria in a Moroccan man living in Tuscany, Italy, August 2018. Euro Surveill. 2018 10; 23(41).
Score: 0.028
-
The role of Quantiferon-TB Gold in-Tube in the diagnosis and treatment monitoring of active tuberculosis. Infect Dis (Lond). 2017 Jun; 49(6):474-477.
Score: 0.025
-
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
Score: 0.008
-
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020 04; 25(17).
Score: 0.008
-
Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.
Score: 0.007
-
Tubercular prosthetic joint infection: two case reports and literature review. Infection. 2018 Feb; 46(1):55-68.
Score: 0.007
-
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
Score: 0.007
-
Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy. Emerg Infect Dis. 2017 05; 23(5):870-872.
Score: 0.006
-
Severe malaria in Europe: an 8-year multi-centre observational study. Malar J. 2017 01 31; 16(1):57.
Score: 0.006